FDA Accepts NDA Filing for Ruxolitinib as a Treatment for Myelofibrosis

  • 4. August 2011
No Comments

WILMINGTON, Del.–(BUSINESS WIRE)–Aug 3, 2011 – IncyteCorporation announced today that the US Food and DrugAdministration (FDA) has accepted for filing the New DrugApplication (NDA) for Incyte’s lead investigational compound,ruxolitinib…

Via (link nur für registrierte Benutzer sichtbar, login oder registriere dich)

Incoming search terms:

  • ruxolitinib
  • ruxolitinib cena
  • ruxolitinib prix
  • lek ruxolitinib

  • leki ruxolitinib
  • nda filing
  • ruxolitinib cena
  • forum utilisateurs ruxilitinib
  • ruxolitinib foro
  • growkessel wien
  • cure of mielofibrose 2011
  • ulotka leku ruxolitinib
  • ruxolitinib italia


More from our blog

See all posts
No Comments